Programme

 

EANM Focus 1, the international conference on “Molecular Imaging and Theranostics in Prostate Cancer”.
The programme consists of 5 tracks. Based on the results, a consensus statement will be produced.

DOWNLOAD PROGRAMME >

 

Thursday, February 1, 2018

Opening Talk

Time Presentation Title Speaker
08:30 – 08:55 Opening and Objectives W. Oyen
S. Fanti

 

Thursday, February 1, 2018

 Staging of High Risk Prostate Cancer

Chairpersons: K. Herrmann, J. van Moorselaar, A. Vargas

Time Presentation Title Speaker
09:00 – 09:25 Clinical Unmet Need at Staging J. van Moorselaar
09:30 – 09:55 Contribution of Radiology for Staging Prostate Cancer A. Vargas
10:00 – 10:25 Contribution of Nuclear Medicine for Staging Prostate Cancer K. Herrmann
11:00 – 11:15 Controversy: Is there still a Role for CT and Bone Scan? H. Scher
11:15 – 11:30 In Favour M. Eiber
11:30 – 11:45 Against G. Antoch
11:45 – 12:00 Questions & Answers
12:00 – 13:00 Consensus on Imaging for Staging HR Prostate Cancer W. Oyen
S. Fanti

 

Thursday, February 1, 2018

Imaging of Biochemical Recurrence of Prostate Cancer

Chairpersons: A. Chiti, J. de Bono, B. Tombal

Time Presentation Title Speaker
14:00 – 14:25 Clinical Unmet Need at Biochemical Recurrence of Prostate Cancer B. Tombal
14:30 – 14:55 Contribution of Radiology at Biochemical Recurrence of Prostate Cancer F. Lecouvet
15:00 – 15:25 Contribution of Nuclear Medicine at Biochemical Recurrence of Prostate Cancer A. Chiti
16:00 – 16:15 Controversy: Should we Address Biochemical Recurrence of Prostate Cancer asap? B. Tombal
16:15 – 16:30 In Favour H. van Poppel
16:30 – 16:45 Against J. de Bono
16:45 – 17:00 Questions & Answers
17:00 – 18:00 Consensus on Imaging for Biochemical Recurrence of Prostate Cancer W. Oyen
S. Fanti

 

Friday, February 2, 2018

Imaging of Advanced Prostate Cancer (CRPC)

Chairpersons: R. Hicks, J. O’Sullivan, A. Padhani

Time Presentation Title Speaker
09:00 – 09:25 Clinical Unmet Need of Advanced Prostate Cancer K. Fizazi
09:30 – 09:55 Contribution of Radiology in mCRPC A. Padhani
10:00 – 10:25 Contribution of Nuclear Medicine in mCRPC R. Hicks
11:00 – 11:15 Controversy: Do we Need Modern Imaging for Oligometastatic Prostate Cancer? J. Walz
11:15 – 11:30 In Favour R. Hicks
11:30 – 11:45 Against J. O’Sullivan
11:45 – 12:00 Questions & Answers
12:00 – 13:00 Consensus on Imaging of Advanced Prostate Cancer (mCRPC) W. Oyen
S. Fanti

 

Friday, February 2, 2018

Therapy of Advanced Prostate Cancer (mCRPC)

Chairpersons: I. Carriò, Noel Clarke, S. Gillessen

Time Presentation Title Speaker
14:00 – 14:25 Oncological Treatment of mCRPC S. Gillesen
14:30 – 14:55 Radium-223 for Treatment of mCRPC N. Clarke
15:00 – 15:25 PSMA Radioligands for Treatment of mCRPC U. Haberkorn
16:00 – 16:15 Controversy: Will Targeted Systemic Radiotherapy Become Clinical Practice? P. Ost
16:15 – 16:30 In Favour I. Carriò
16:30 – 16:45 Against N. Clarke
16:45 – 17:00 Questions & Answers
17:00 – 18:00 Consensus on Targeted Systemic Radiotherapy of Advanced mCRPC  W. Oyen
S. Fanti

 

Saturday, February 3, 2018

New Prostate Cancer Targets for Imaging and Therapy

Chairpersons: J. Schalken, U. Haberkorn

Time Presentation Title Speaker
09:00 – 09:20 Potential New Pathways J. Schalken
09:20 – 09:40 Role of Prostate Cancer Genetics J. de Bono
09:40 – 10:00 Pathologist’s Perspective R. Montironi
10:00 – 10:20 Radiopharmaceutical Developments H.-J. Wester
10:20 – 10:40 Perspective Discussion J. de Bono
11:00 – 11:20 Patient’s Perspective I. Banks
11:20 – 11:40 Foundation’s Perspective  S. Gledhill
11:40 – 12:00 Consensus on Relevant Factors to Build a Consensus all panellists,

chairpersons:

S. Fanti,
H. Scher

12:00 – 12:45 Summary on Results and Debate with all Participants all panellists,

chairpersons:

S. Gillessen,
W. Oyen

12:45 – 13:00 Future Directions & Closing Remarks S. Fanti,
W. Oyen